These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3341067)

  • 1. Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1.
    Menitove JE; Kagen LR; Aster RH
    Transfusion; 1988; 28(1):56-8. PubMed ID: 3341067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of PGE1 for preparation of platelet concentrates.
    Menitove JE; Frenzke M; Aster RH
    Transfusion; 1986; 26(4):346-50. PubMed ID: 2941906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of prostaglandin E1 during preparation of platelet concentrates.
    Hawker RJ; Turner VS; Mitchell SG
    Transfus Med; 1996 Sep; 6(3):249-54. PubMed ID: 8885155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin E1 and theophylline.
    Bode AP; Holme S; Heaton WA; Swanson MS
    Vox Sang; 1991; 60(2):105-12. PubMed ID: 2031336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
    Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA
    Artery; 1993; 20(6):303-13. PubMed ID: 8010886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 and dibutyryl cyclic AMP enhance platelet resistance to deformation.
    Wang DL; Chang YN; Hsu HT; Usami S; Chien S
    Thromb Res; 1992 Mar; 65(6):757-68. PubMed ID: 1321994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.
    Sinzinger H; O'Grady J; Fitscha P
    Postgrad Med J; 1987 Apr; 63(738):245-7. PubMed ID: 3684830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PGE1 on platelet deformability.
    Chang YN; Hsu HT; Hung MS; Chang CL; Li JG; Wang DL
    Chin J Physiol; 1990; 33(1):31-40. PubMed ID: 2165451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandin E1 on platelet attenuation of oxidant-induced edema in isolated rabbit lungs.
    Heffner JE; Baron DA
    J Lab Clin Med; 1990 Dec; 116(6):797-804. PubMed ID: 2246556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
    Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
    Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors.
    Holme S; Bode A; Heaton WA; Sawyer S
    J Lab Clin Med; 1992 Feb; 119(2):144-50. PubMed ID: 1740627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion.
    Fantone JC; Kunkel RG; Kinnes DA
    Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.